NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Chipping away at the chip bias: RNA degradation in microarray analysis.

Author(s): Auer H, Lyianarachchi S, Newsom D, Klisovic MI, Marcucci G, Kornacker K

Publication: Nat Genet, 2003, Vol. 35, Page 292-3

PubMed ID: 14647279 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effect of RNA degradation on transcript quantification by microarray analysis.

Conclusion of Paper

Storing a specimen for 5 minutes at room temperature prior to RNA extraction or adding a cellular extract after RNA purification resulted in 75% of transcripts appearing to be differentially expressed by microarray analysis when compared to undegraded specimens. Importantly, the false positives, but not the false negatives showed a linear correlation with RNA degradation. The 3'/5' ratio of Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and beta actin (ACTB) transcripts correlated strongly with degradation in aorta specimens (R2=0.65), but not well with bone marrow specimens (R2=0.16).

Studies

  1. Study Purpose

    The purpose of this paper was to determine the effect of RNA degradation on transcript quantification by microarray analysis. RNA from peripheral blood mononuclear cells was degraded prior to processing by leaving the specimen at RT for 5 min or after processing by the addition of cellular extract. RNA degradation was determined using an author-developed model.

    Summary of Findings:

    Storing a specimen for 5 minutes at room temperature prior to RNA extraction or adding a cellular extract after RNA purification resulted in 75% of transcripts appearing to be differentially expressed by microarray analysis when compared to undegraded specimens. Importantly the false positives, but not the false negatives show a linear correlation with RNA degradation. The 3'/5' ratio of GAPDH and ACTB transcripts correlated strongly with degradation in aorta specimens (R2=0.65), but not well with bone marrow specimens (R2=0.16).

    Biospecimens
    Preservative Types
    • None (Fresh)
    • Frozen
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    RNA DNA microarray
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Blood and blood products Peripheral blood mononuclear cells
    Biospecimen Preservation Type of fixation/preservation None (fresh)
    Snap frozen
    Analyte Extraction and Purification Analyte isolation method Trizol extraction immediately after thawing PBMC
    Trizol extraction after thawing and 5 min at room temperature
    Trizol extraction immediately following PBMC isolation
    Second trizol extraction following incubation of PBMC with endogenous RNAses
    Biospecimen Acquisition Biospecimen location Skin
    Natural killer cells
    Aorta
    Peripheral blood
    Bone marrow

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...